Take the Reins: The Effects of Nutrient Timing on Cancer-related Fatigue
Recruiting
Phase 2
Interventional Study
Neoplasms
Blood Cancer
Fatigue
Diet Habit
Survivorship
Fasting, Intermittent
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 96 (estimated)
- Sponsor
- University of Maryland, Baltimore · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Cancer-related fatigue affects at least 30-90% of patients with cancer, depending on the type of cancer and their treatment(s) (e.g., chemotherapy, radiation). It is not relieved by sleep or rest, and it sometimes can persist for years after a person's cancer was treated. The fatigue can be so bad that people cannot return to work, hobbies, family roles, or other daily activities, thereby greatly …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion criteria (Participants must…):
* Have a diagnosis of a hematologic neoplasm (e.g., leukemia, lymphoma, multiple myeloma);
* Be at least 2 months post-treatment with chemotherapy, radiation, targeted therapy, chimeric antigen receptor (CAR)-T cell therapy, stem cell transplant, or another …
Contacts